NPPA holds discussion with pharma bodies on GST implementation

National Pharmaceutical Pricing Authority (NPPA), has revealed that it met several pharma sector associations to decide the way forward for implementation of the GST

New Delhi: National Pharmaceutical Pricing Authority (NPPA), the national drug pricing regulator recently met several pharma sector associations to decide the way ahead after the Goods and Service Tax (GST) implementation scheduled on July 1, 2017.
As per the regulator, the aim of these meetings was to discuss a range of issues related to the sector as well as to ensure an uninterrupted supply of the drugs across India.
“NPPA holds fruitful discussions with industry and trade associations to ensure uninterrupted supply of drugs on the implementation of GST,” revealed the National Pharmaceutical Pricing Authority (NPPA) on a microblogging website, Twitter.
The top associations that held deliberations with the NPPA included Indian Pharmaceutical Alliance (IPA), All India Organisation of Chemists and Druggists (AIOCD), Organisation of Pharmaceutical Producers of India (OPPI), and Indian Drug Manufacturers Association (IDMA).